Henan Lingrui Pharmaceutical Co Ltd Cash Flow Quality Index
Henan Lingrui Pharmaceutical Co Ltd cash flow quality index. Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Quality Index of 0.79x as of September 2025. Operating cash flow of CN¥140.12 Million is below net income of CN¥176.55 Million, suggesting accrual-heavy earnings not yet converted to cash. See 600285 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Cash flow quality index of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. Historical Cash Flow Quality Index for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Henan Lingrui Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2025)
Henan Lingrui Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Henan Lingrui Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Henan Lingrui Pharmaceutical Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.73x | CN¥553.88 Million | CN¥759.50 Million | ▼ -39.8% |
| 2024 | 1.21x | CN¥875.86 Million | CN¥722.58 Million | ▼ -15.3% |
| 2023 | 1.43x | CN¥813.43 Million | CN¥568.11 Million | ▼ -20.2% |
| 2022 | 1.79x | CN¥834.91 Million | CN¥465.33 Million | ▼ -23.1% |
| 2021 | 2.33x | CN¥845.69 Million | CN¥362.50 Million | ▲ +68.0% |
| 2020 | 1.39x | CN¥450.53 Million | CN¥324.38 Million | ▼ -9.6% |
| 2019 | 1.54x | CN¥450.15 Million | CN¥293.15 Million | ▼ -13.5% |
| 2018 | 1.78x | CN¥436.25 Million | CN¥245.77 Million | ▲ +276.8% |
| 2017 | 0.47x | CN¥105.97 Million | CN¥224.93 Million | ▲ +159.0% |
| 2016 | 0.18x | CN¥63.26 Million | CN¥347.72 Million | ▼ -84.5% |
| 2015 | 1.17x | CN¥156.82 Million | CN¥133.71 Million | ▼ -28.1% |
| 2014 | 1.63x | CN¥124.32 Million | CN¥76.22 Million | ▲ +35.1% |
| 2013 | 1.21x | CN¥127.27 Million | CN¥105.39 Million | ▲ +226.7% |
| 2012 | 0.37x | CN¥15.43 Million | CN¥41.76 Million | ▼ -72.9% |
| 2011 | 1.36x | CN¥40.49 Million | CN¥29.67 Million | ▲ +1769.3% |
| 2010 | -0.08x | CN¥-3.95 Million | CN¥48.34 Million | ▼ -101.8% |
| 2009 | 4.49x | CN¥132.61 Million | CN¥29.51 Million | ▲ +13.5% |
| 2008 | 3.96x | CN¥43.72 Million | CN¥11.04 Million | ▲ +1684.4% |
| 2007 | 0.22x | CN¥15.99 Million | CN¥72.03 Million | ▼ -91.0% |
| 2006 | 2.48x | CN¥26.76 Million | CN¥10.80 Million | ▲ +35.2% |
| 2005 | 1.83x | CN¥33.43 Million | CN¥18.23 Million | ▼ -27.7% |
| 2004 | 2.54x | CN¥35.51 Million | CN¥13.99 Million | ▲ +42.7% |
| 2003 | 1.78x | CN¥23.79 Million | CN¥13.38 Million | ▼ -66.8% |
| 2002 | 5.36x | CN¥69.41 Million | CN¥12.96 Million | ▲ +3843.4% |
| 2001 | 0.14x | CN¥3.41 Million | CN¥25.11 Million | ▲ +1.6% |
| 2000 | 0.13x | CN¥3.66 Million | CN¥27.40 Million | ▼ -69.3% |
| 1999 | 0.43x | CN¥4.81 Million | CN¥11.06 Million | — |